These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 24030976

  • 1. MYC phosphorylation at novel regulatory regions suppresses transforming activity.
    Wasylishen AR, Chan-Seng-Yue M, Bros C, Dingar D, Tu WB, Kalkat M, Chan PK, Mullen PJ, Huang L, Meyer N, Raught B, Boutros PC, Penn LZ.
    Cancer Res; 2013 Nov 01; 73(21):6504-15. PubMed ID: 24030976
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification of novel Myc target genes with a potential role in lymphomagenesis.
    Marinkovic D, Marinkovic T, Kokai E, Barth T, Möller P, Wirth T.
    Nucleic Acids Res; 2004 Nov 01; 32(18):5368-78. PubMed ID: 15477387
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
    Chou YT, Lin HH, Lien YC, Wang YH, Hong CF, Kao YR, Lin SC, Chang YC, Lin SY, Chen SJ, Chen HC, Yeh SD, Wu CW.
    Cancer Res; 2010 Nov 01; 70(21):8822-31. PubMed ID: 20978205
    [Abstract] [Full Text] [Related]

  • 7. Mammary tumor formation and metastasis evoked by a HER2 splice variant.
    Alajati A, Sausgruber N, Aceto N, Duss S, Sarret S, Voshol H, Bonenfant D, Bentires-Alj M.
    Cancer Res; 2013 Sep 01; 73(17):5320-7. PubMed ID: 23867476
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
    Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS, Penn LZ.
    Cancer Res; 2006 May 15; 66(10):5330-7. PubMed ID: 16707459
    [Abstract] [Full Text] [Related]

  • 10. A novel MASH1 enhancer with N-myc and CREB-binding sites is active in neuroblastoma.
    Watt F, Watanabe R, Yang W, Agren N, Arvidsson Y, Funa K.
    Cancer Gene Ther; 2007 Mar 15; 14(3):287-96. PubMed ID: 17124508
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.
    Gavert N, Shvab A, Sheffer M, Ben-Shmuel A, Haase G, Bakos E, Domany E, Ben-Ze'ev A.
    Cancer Res; 2013 Sep 15; 73(18):5754-63. PubMed ID: 24008320
    [Abstract] [Full Text] [Related]

  • 14. Direct recruitment of N-myc to target gene promoters.
    Mac SM, D'Cunha CA, Farnham PJ.
    Mol Carcinog; 2000 Oct 15; 29(2):76-86. PubMed ID: 11074604
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant.
    Thibodeaux CA, Liu X, Disbrow GL, Zhang Y, Rone JD, Haddad BR, Schlegel R.
    Breast Cancer Res Treat; 2009 Jul 15; 116(2):281-94. PubMed ID: 18642118
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of cathepsin proteases attenuates migration and sensitizes aggressive N-Myc amplified human neuroblastoma cells to doxorubicin.
    Gangoda L, Keerthikumar S, Fonseka P, Edgington LE, Ang CS, Ozcitti C, Bogyo M, Parker BS, Mathivanan S.
    Oncotarget; 2015 May 10; 6(13):11175-90. PubMed ID: 25883214
    [Abstract] [Full Text] [Related]

  • 18. CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc.
    Pu H, Zheng Q, Li H, Wu M, An J, Gui X, Li T, Lu D.
    Oncotarget; 2015 Dec 01; 6(38):40775-98. PubMed ID: 26513297
    [Abstract] [Full Text] [Related]

  • 19. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
    Takatsuno Y, Mimori K, Yamamoto K, Sato T, Niida A, Inoue H, Imoto S, Kawano S, Yamaguchi R, Toh H, Iinuma H, Ishimaru S, Ishii H, Suzuki S, Tokudome S, Watanabe M, Tanaka J, Kudo SE, Mochizuki H, Kusunoki M, Yamada K, Shimada Y, Moriya Y, Miyano S, Sugihara K, Mori M.
    Ann Surg Oncol; 2013 Apr 01; 20(4):1395-402. PubMed ID: 22976378
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.